Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
551
-
Total 13F shares, excl. options
-
185M
-
Shares change
-
+2.75M
-
Total reported value, excl. options
-
$15.2B
-
Value change
-
+$201M
-
Put/Call ratio
-
0.72
-
Number of buys
-
276
-
Number of sells
-
-260
-
Price
-
$82.33
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2024
687 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2024.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 551 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 185M shares
of 194M outstanding shares and own 95.56% of the company stock.
Largest 10 shareholders include BlackRock Inc. (22.7M shares), VANGUARD GROUP INC (19M shares), PRIMECAP MANAGEMENT CO/CA/ (18.8M shares), Dodge & Cox (13.9M shares), Capital Research Global Investors (9.69M shares), STATE STREET CORP (9.64M shares), VIKING GLOBAL INVESTORS LP (7.06M shares), AMERIPRISE FINANCIAL INC (4.7M shares), Avoro Capital Advisors LLC (4.56M shares), and NORGES BANK (3.62M shares).
This table shows the top 551 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.